Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Serum Albumin (ALB) - Drugs in Development, 2021
US$ 3,000.00
Serum Albumin (ALB) - Drugs in Development, 2021 SUMMARY Serum Albumin (ALB) - Drugs in Development, 2021 provides in depth analysis on Serum Albumin (ALB) targeted pipeline therapeutics. The report p...
April 2021
30 pages
Sezary Syndrome (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Sezary Syndrome (Oncology) - Drugs in Development, 2021 SUMMARY Sezary Syndrome (Oncology) - Drugs in Development, 2021 provides an overview of the Sezary Syndrome pipeline landscape. The report provi...
April 2021
55 pages
Sirtuin (SIRT or EC 2.3.1.) - Drugs in Development, 2021
US$ 3,000.00
Sirtuin (SIRT or EC 2.3.1.) - Drugs in Development, 2021 SUMMARY Sirtuin (SIRT or EC 2.3.1.) - Drugs in Development, 2021 provides in depth analysis on Sirtuin (SIRT or EC 2.3.1.) targeted pipeline th...
April 2021
30 pages
Skin Infections (Dermatology) - Drugs in Development, 2021
US$ 2,000.00
Skin Infections (Dermatology) - Drugs in Development, 2021 SUMMARY Skin Infections (Dermatology) - Drugs in Development, 2021 provides an overview of the Skin Infections pipeline landscape. The report...
April 2021
45 pages
Skin Ulcers (Dermatology) - Drugs in Development, 2021
US$ 2,000.00
Skin Ulcers (Dermatology) - Drugs in Development, 2021 SUMMARY Skin Ulcers (Dermatology) - Drugs in Development, 2021 provides an overview of the Skin Ulcers pipeline landscape. The report provides co...
April 2021
30 pages
Sleep Apnea (Respiratory) - Drugs in Development, 2021
US$ 2,000.00
Sleep Apnea (Respiratory) - Drugs in Development, 2021 SUMMARY Sleep Apnea (Respiratory) - Drugs in Development, 2021 provides an overview of the Sleep Apnea pipeline landscape. The report provides co...
April 2021
30 pages
Soft Tissue Sarcoma (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Soft Tissue Sarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Soft Tissue Sarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Soft Tissue Sarcoma pipeline landscape. The...
April 2021
220 pages
